-
Preclinical Tests Show Antibody Stops Covid-19 Variants
Lab studies show an experimental synthetic antibody protects animals and neutralizes all SARS-CoV-2 variants of concern, including omicron BA.2.
-
Synthetic Bio Companies Partner on Therapeutic Microbes
A developer of therapies from engineered microbes is collaborating with a synthetic biology components company on tools to create engineered gut bacteria.
-
Natural Killer Cells Stop Ovarian Cancer in Preclinical Test
Results from a lab study show engineered immune system cells sharply reduce tumors and extend survival in mice grafted with a type of ovarian cancer.
-
Infographic – Biotech Index Plunge Continues in Q1
Since the beginning of 2022, the Nasdaq Biotechnology Index, an indicator of investor sentiment in the industry, has declined about 10 percent.
-
Lung Chip Reveals Respiratory Immune Responses
A study with a small chip device simulating human lung functions shows normal breathing generates immune responses that protect against respiratory diseases.
-
Biotech, Synthetic Bio Companies Partner on T-Cell Therapies
A company creating antibodies from synthetic DNA and a developer of engineered T-cells are collaborating on new antibodies to produce T-cell therapeutics.
-
NASA Supporting Electric Alternative to Rocket Launch
A company creating an electric-powered launch technology says NASA agreed to a test later this year of a space satellite launched in low earth orbit.
-
Trial to Test AI-Designed Cancer Antibody Therapy
A clinical trial is set to begin evaluating a synthetic antibody treatment for solid tumor cancer designed with machine learning algorithms.
-
Antimicrobial Resistance Fund Invests in Two Biotechs
A pharmaceutical industry venture fund is investing in two developers of new treatments for bacterial infections becoming resistant to antibiotics.
-
Infographic – AI Help Wanted by Workers
Gartner Inc. polled U.S. consumers about their views of A.I. in the workplace and found a number of tasks for which workers would accept A.I.’s help.